To investigate a role for the inflammatory mediator, nitric oxide (NO) in Sjögren"s syndrome, an autoimmune condition characterised by salivary and lacrimal gland hypofunction resulting from failure of acinar cells to secrete. significantly reduced the ACh-evoked Ca 2+ signal by a mechanism independent of cyclic GMP. We found no differences between the responses of human and mouse acinar cells.
Introduction
Sjögren"s syndrome is an autoimmune condition in which salivary glands lose the capacity to secrete saliva. For many years, it has been assumed that secretion declined along with the physical atrophy of the glands, which is clearly apparent by the end stages of the disease. More recently, it has been demonstrated that the loss of function precedes the loss of glandular tissue and that many patients who are incapable of saliva production nevertheless have histologically normal acinar tissue that is functional in vitro [1] . Glandular hypofunction cannot be a consequence of atrophy in these patients as their glandular tissue has not atrophied.
We have proposed an alternative, non-apoptotic model to account for glandular hypofunction in Sjögren"s syndrome in which lack of function follows interaction between the autoimmune response and stimulus-secretion coupling [2] . Exploration of this model requires some understanding of the mechanisms of stimulus secretion coupling, the "core" elements of which are widely understood to be: (a) activation of to the increase in [Ca 2+ ] i Fluid secretion is driven by Cl -efflux across the apical membrane of the acinar cells [3] .
In principle, any aspect of the immune response that prevented production of IP 3 and or Ca 2+ mobilisation is a candidate for a pathogenic role in Sjögren"s syndrome. In fact, the range of potential antisecretory agents is much wider, because stimulussecretion coupling is more complex than the simple description of the "core" elements would suggest [4, 5] . Effective stimulus-secretion coupling does not necessarily follow any Ca 2+ signal, but rather requires an appropriate signal in an appropriate place at an appropriate time [5] . For example, whereas a small brief increase in [Ca 2+ ] i at the apical pole of the cell might be sufficient to trigger secretion, the same signal at the basolateral pole would likely not [6] . is regulated by cyclic ADP ribose concentration which is itself be regulated by cGMP levels [7] .
Any factor that regulates cGMP and or cADP ribose levels has therefore the capacity to alter stimulus-secretion coupling independently of any direct effect on IP 3 production or on IP 3 -dependent Ca 2+ release. One such factor is Nitric Oxide (NO), which activates guanylate cyclase and stimulates cGMP production.
In terms of our model for secretion, increased NO levels should amplify the ACh- 
Methods

Solutions
The extracellular bathing solution contained in mM: 140 NaCl, 4. 
Mouse Acinar cell collection
Adult male CD1 mice were killed by cervical dislocation and submandibular acinar cells were isolated by collagenase (100units/ml, Worthington Diagnostic USA) digestion in extracellular media containing 1mM Ca 2+ as described previously [9] .
Briefly: glands were removed from the animal, stripped of surrounding capsule, 
Human Acinar cell collection
Following local ethical approval (Sefton LREC, EC.38.02) and informed written consent, small portions of human submandibular glands were collected, at the time of surgery, from patients undergoing submandibular gland removal as part of routine head and neck surgery. The small size of the gland portion collected for research did not interfere with the subsequent diagnosis and treatment of the patient. All collected samples were transported to the laboratory on ice in "acinar cell culture media" within 1 hour of removal. Acinar cells were isolated from the human tissue using the same techniques employed to isolate mouse acinar cells [9] .
Acinar Cell preparation
Following dispersal, cells were suspended in "Acinar cell culture media" and placed onto circular glass coverslips (22mm diameter) coated with a thin (≈1 mm) layer of a basement membrane matrix (Matrigel, Becton Dickinson, UK) 25. Each coverslip was placed into one well of a 6 well plate and covered with "Acinar cell culture media" and kept overnight at 37 o C with 5% CO 2 .
Microfluorimetry
Cells were removed from culture immediately before an experiment and loaded with The ratio of UV light emitted at 510nm following excitation at 340nm to that emitted following excitation at 380nm was measured using a Cairn (Cairn Research Ltd, Faversham, Kent, UK) spectrophotometer (Excitation was at 96Hz, data were averaged online and collected at 4Hz.). Intracellular Ca 2+ activity was calculated from this ratio using the Grynkiewiez equation and custom written software. Averaged changes in Ca 2+ were calculated from the plateau phase of the Ca 2+ signal.
NO Donors and Inhibitors
Cells were exposed to NO by perfusion with two chemically different donors: S- 
Statistics
Numerical data are presented as mean ± Standard Error of the mean (number of observations). Significance was determined using Student"s t test.
Results
We have designed a protocol to show whether exposure to NO affects the AChevoked Ca 2+ signal. The most easily quantifiable Ca 2+ signal is a small steady-state increase in response to a low level of ACh stimulation. Figure 1A shows the response of mouse submandibular acinar cells to repeated stimulation with 50nM ACh. The resultant increase in Ca 2+ is highly reproducible in any one cell. Figures 1B and C show that exposure to NO released by the donors SNAP (100 µM) and NOC-12 (200 µM) respectively, increased the response to ACh. On average, under control conditions, the response to the third application of ACh was 103.7 ± 2.9 % that of the first (n=13). When exposed to SNAP after the second application of ACh, the response to subsequent stimulation rose to 226.5 ± 30.9 % of that before application of SNAP (n=7). Similarly, exposure to NOC-12 increased the response to 168.2 ± 12.8 % (n=16) of that seen before application. The amplification induced by either NO donor was statistically significant at P <0.01. In some experiments, particularly those where a higher concentrations of SNAP (>=200 M, data not shown) was employed, baseline Ca 2+ also increased, as described previously by Looms et al [10] .
In other experiments using lower concentrations of NO donor, the Ca 2+ baseline remained constant. Following exposure to NOC-12, the increase was 127.7 ± 9.1 (n=3). Compared to control, the amplification induced by NOC-12 was statistically significant at P<0.05.
These data show that NO amplified the ACh-evoked Ca 2+ signal. We hypothesise that this amplification is mediated through cGMP stimulation of cADPr production following NO-stimulation of guanylate cyclase. Guanylate cyclase activity may be inhibited using 1 This last observation was typical of 6/7 similar experiments.
The response to 50nM ACh stimulation following a prolonged pre-incubation (2-5 hours) in the presence of 200 µM NOC-12 was measured (trace not shown) and found to be on average 49.7 ± 24.3% (n=9) of the averaged first response to ACh seen without preincubation. These data cannot easily be directly compared to those obtained using the repetitive stimulation protocol, however it is clear that the response to ACh is both lower than that seen without exposure to NOC-12 and also that prolonged exposure to NOC-12 alone did not completely abolish the response to ACh.
The data in figure 5D (mouse submandibular cells) show that application of the guanylate cyclase inhibitor ODQ (1 µM) had no effect on the inhibition of the ACh- & 2) . This is most likely the result of NO release, rather than an artefact of a particular NO donor because similar enhancement was seen using two chemically unrelated NO donors, SNAP and NOC-12, and also with sodium nitroprusside (data not shown).
Inhibition by ODQ ( figure 3 ) of the effect of the NO donor indicates that the enhancement was mediated through cGMP. Inhibition by ryanodine indicates involvement of RyR ( figure 3 ). Together these data confirm the prediction of the model, that NO is able to up-regulate stimulus secretion coupling by increasing the contribution of Ca 2+ release via RyR to the Ca 2+ signal.
These data would seem to make a role for NO in the aetiology of Sjögren"s syndrome less likely. However, the data in figure 5 , where the effect of longer exposure to NO is examined, indicate that this is not the case. The enhancement of the ACh-evoked be accounted for by the "Model for Secretion" (see introduction) but they are nevertheless consistent with the observation that NO levels are elevated in Sjögren"s syndrome patients [8] . We have previously shown in labial glands from patients with Sjögren"s syndrome that the concentration dependence of the ACh response is shifted to the right, i.e. these cells are less sensitive to stimulation [1] . This is exactly what we have observed in cells chronically exposed to NO.
The effect of chronic exposure to NO was not prevented by the guanylate cyclase inhibitor ODQ which suggests that the inhibitory effect is not mediated through cGMP. We have little evidence at present to indicate the mechanism by which NO inhibits stimulus-secretion coupling. The Ca 2+ stores do appear to be still functional, inasmuch as Ca 2+ may still be mobilised by the SERCA pump inhibitor thapsigargin after the response to ACh has diminished (figure 5C). Although, by itself a crude indicator, the thapsigargin data would suggest the effect of NO is not simply depletion of stored Ca 2+ .
Whilst activation of soluble guanylate cyclase by NO binding to the haeme moiety of the enzyme remains the best understood mechanism by which NO affects cellular function [11] , it is far from the only one. NO also contributes to both cellular physiology and pathophysiology through its role in triggering apoptosis, which is mediated through reactive nitrogen species (RNS) [12] . Furthermore, apoptosis is not an inevitable or even the only consequence of the production of RNS [13] and there is a growing body of evidence to indicate that reversible changes in the redox state of cysteine thiols can modulate many protein functions [14] .
One protein in which the effects of nitrosylation have been extensively studied is the ryanodine receptor [15, 16] and it has been hypothesised that NO-mediated nitrosylation of RyR dubbed "redox signalling" [14, 17] could comprise an important regulator of the signal transduction process [18] . It is very difficult to predict with any certainty the impact that nitrosylation of the ryanodine receptor might have on stimulus-secretion coupling because the specificity with which cysteine residues are nitrosylated depends on many factors including the subcellular distribution of the target protein and the local chemical environment in which it is found [16, 18, 19] .
Nevertheless, inhibition of RyR activity through nitrosylation could possibly account for our observations of an inhibition of the Ca 2+ signal following prolonged exposure to NO donor.
We have no direct evidence that NO is down regulating RyR function through nitrosylation and furthermore, RyR is not the only component of the stimulussecretion cascade that could be targeted by nitrosylation. Studies on RyR and many other proteins have identified concensus motifs likely to be nitrosylated [23, 24] and IP 3 receptors [25] also share these motifs. Store gated Ca 2+ influx is also thought to modified by NO [26, 27] and nitrosylation could also alter muscarinic receptor function by altering the distribution of receptors at the cell surface [28, 29] .
Our observations are consistent with a role for NO in glandular hypofunction by a cGMP independent mechanism, possibly via S-nitrosylation of a key component of the stimulus-secretion cascade. These data could go some way towards explaining the right-shift in the ACh concentration dependence that we have seen in human labial gland cells from Sjögren"s syndrome patients [1] because NO is known to be elevated in Sjögren"s syndrome [8, [30] [31] [32] . Together these data support the concepts outlined in "A non-apoptotic model for Sjögren's syndrome" [2] and introduce mechanisms whereby not only amplification but also pathological inhibition of salivary secretion might be mediated by NO. 
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